Waters (NYSE:WAT) Issues FY 2025 Earnings Guidance

Waters (NYSE:WAT) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 13.050-13.150 for the period, compared to the consensus EPS estimate of 12.990. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.1 billion. Waters also updated its Q4 2025 guidance to 4.450-4.550 EPS.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Jefferies Financial Group set a $385.00 price target on Waters and gave the stock a “buy” rating in a research note on Monday, August 4th. JPMorgan Chase & Co. lifted their target price on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Scotiabank reaffirmed a “sector outperform” rating and issued a $465.00 target price on shares of Waters in a research note on Friday, July 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Finally, Rothschild Redb upgraded shares of Waters to a “strong-buy” rating in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Waters has an average rating of “Moderate Buy” and an average price target of $375.54.

Waters Stock Down 1.0%

Shares of Waters stock opened at $346.02 on Tuesday. Waters has a 12-month low of $275.05 and a 12-month high of $423.56. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The company’s fifty day simple moving average is $317.68 and its two-hundred day simple moving average is $324.75. The company has a market cap of $20.60 billion, a P/E ratio of 31.20, a PEG ratio of 3.19 and a beta of 1.04.

Waters (NYSE:WAT) last issued its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. Research analysts anticipate that Waters will post 12.86 EPS for the current year.

Institutional Investors Weigh In On Waters

A number of institutional investors have recently modified their holdings of WAT. MUFG Securities EMEA plc purchased a new stake in shares of Waters in the second quarter worth $61,000. State of Wyoming purchased a new stake in Waters during the 2nd quarter valued at about $75,000. Headlands Technologies LLC purchased a new stake in Waters during the 2nd quarter valued at about $135,000. EverSource Wealth Advisors LLC grew its position in Waters by 82.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 386 shares of the medical instruments supplier’s stock valued at $135,000 after purchasing an additional 175 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Waters during the second quarter valued at approximately $232,000. 94.01% of the stock is owned by hedge funds and other institutional investors.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.